| Source HCPCS Code |
|
Target NDC Code |
Q5117
INJECTION, TRASTUZUMAB-ANNS, BIOSIMILAR, (KANJINTI), 10 MG
|
⇄
|
55513-0132-01
KANJINTI (PF,LYOPHILIZED) 420 MG
|
| Detail Information |
| Relationship Start Date |
10/01/2019 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
Q5117
INJECTION, TRASTUZUMAB-ANNS, BIOSIMILAR, (KANJINTI), 10 MG
|
⇄
|
55513-0141-01
KANJINTI (SDV,PF,LATEX-FREE) 150 MG
|
| Detail Information |
| Relationship Start Date |
11/04/2019 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
Q5117
INJECTION, TRASTUZUMAB-ANNS, BIOSIMILAR, (KANJINTI), 10 MG
|
⇄
|
55513-0164-01
KANJINTI KIT (W/DILUENT,PF) 420 MG
|
| Detail Information |
| Relationship Start Date |
05/01/2023 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
Q5117
Inj., kanjinti, 10 mg
|
⇄
|
55513-0164-01
Kanjinti (Kit)
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q5117
Inj., kanjinti, 10 mg
|
⇄
|
55513-0132-01
Kanjinti
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q5117
Inj., kanjinti, 10 mg
|
⇄
|
55513-0141-01
Kanjinti
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|